273 related articles for article (PubMed ID: 27441640)
21. Consensus small interfering RNA targeted to stem-loops II and III of IRES structure of 5' UTR effectively inhibits virus replication and translation of HCV sub-genotype 4a isolates from Saudi Arabia.
AlMalki WH; Shahid I; Abdalla AN; Johargy AK; Ahmed M; Hassan S
Saudi J Biol Sci; 2021 Jan; 28(1):1109-1122. PubMed ID: 33424405
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.
Khaliq S; Jahan S; Ijaz B; Ahmad W; Asad S; Pervaiz A; Samreen B; Khan M; Hassan S
Virol J; 2010 Nov; 7():318. PubMed ID: 21073745
[TBL] [Abstract][Full Text] [Related]
23. Silencing of hepatitis C virus replication by a non-viral vector based on solid lipid nanoparticles containing a shRNA targeted to the internal ribosome entry site (IRES).
Torrecilla J; Del Pozo-Rodríguez A; Solinís MÁ; Apaolaza PS; Berzal-Herranz B; Romero-López C; Berzal-Herranz A; Rodríguez-Gascón A
Colloids Surf B Biointerfaces; 2016 Oct; 146():808-17. PubMed ID: 27451369
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region.
Wilson JA; Richardson CD
J Virol; 2005 Jun; 79(11):7050-8. PubMed ID: 15890944
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of full length hepatitis C virus particles of 1a genotype through small interference RNA.
Ansar M; Ashfaq UA; Shahid I; Sarwar MT; Javed T; Rehman S; Hassan S; Riazuddin S
Virol J; 2011 May; 8():203. PubMed ID: 21535893
[TBL] [Abstract][Full Text] [Related]
26. To accelerate the Zika beat: Candidate design for RNA interference-based therapy.
Giulietti M; Righetti A; Cianfruglia L; Šabanović B; Armeni T; Principato G; Piva F
Virus Res; 2018 Aug; 255():133-140. PubMed ID: 30031046
[TBL] [Abstract][Full Text] [Related]
27. Seed sequence-matched controls reveal limitations of small interfering RNA knockdown in functional and structural studies of hepatitis C virus NS5A-MOBKL1B interaction.
Chung HY; Gu M; Buehler E; MacDonald MR; Rice CM
J Virol; 2014 Oct; 88(19):11022-33. PubMed ID: 25031347
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of hepatitis C virus RNA replication by short hairpin RNA synthesized by T7 RNA polymerase in hepatitis C virus subgenomic replicons.
Hamazaki H; Ujino S; Miyano-Kurosaki N; Shimotohno K; Takaku H
Biochem Biophys Res Commun; 2006 May; 343(3):988-94. PubMed ID: 16566896
[TBL] [Abstract][Full Text] [Related]
29. The efficacy of siRNAs against hepatitis C virus is strongly influenced by structure and target site accessibility.
Sagan SM; Nasheri N; Luebbert C; Pezacki JP
Chem Biol; 2010 May; 17(5):515-27. PubMed ID: 20534349
[TBL] [Abstract][Full Text] [Related]
30. Silencing of hepatitis A virus infection by small interfering RNAs.
Kusov Y; Kanda T; Palmenberg A; Sgro JY; Gauss-Müller V
J Virol; 2006 Jun; 80(11):5599-610. PubMed ID: 16699041
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of HCV replication by small interfering RNA.
Ray RB; Kanda T
Methods Mol Biol; 2009; 510():251-62. PubMed ID: 19009267
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents.
Wose Kinge CN; Espiritu C; Prabdial-Sing N; Sithebe NP; Saeed M; Rice CM
Antimicrob Agents Chemother; 2014 Sep; 58(9):5386-94. PubMed ID: 24982066
[TBL] [Abstract][Full Text] [Related]
33. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
[TBL] [Abstract][Full Text] [Related]
34. In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus.
Watanabe T; Hatakeyama H; Matsuda-Yasui C; Sato Y; Sudoh M; Takagi A; Hirata Y; Ohtsuki T; Arai M; Inoue K; Harashima H; Kohara M
Sci Rep; 2014 Apr; 4():4750. PubMed ID: 24756133
[TBL] [Abstract][Full Text] [Related]
35. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.
Lam AM; Murakami E; Espiritu C; Steuer HM; Niu C; Keilman M; Bao H; Zennou V; Bourne N; Julander JG; Morrey JD; Smee DF; Frick DN; Heck JA; Wang P; Nagarathnam D; Ross BS; Sofia MJ; Otto MJ; Furman PA
Antimicrob Agents Chemother; 2010 Aug; 54(8):3187-96. PubMed ID: 20516278
[TBL] [Abstract][Full Text] [Related]
36. Positional effects and strand preference of RNA interference against hepatitis C virus target sequences.
Smith RM; Smolic R; Volarevic M; Wu GY
J Viral Hepat; 2007 Mar; 14(3):194-212. PubMed ID: 17305886
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs.
Chang B; Lee CH; Lee JH; Lee SW
Biotechnol Lett; 2010 Sep; 32(9):1231-7. PubMed ID: 20464448
[TBL] [Abstract][Full Text] [Related]
38. Cellular cofactors affecting hepatitis C virus infection and replication.
Randall G; Panis M; Cooper JD; Tellinghuisen TL; Sukhodolets KE; Pfeffer S; Landthaler M; Landgraf P; Kan S; Lindenbach BD; Chien M; Weir DB; Russo JJ; Ju J; Brownstein MJ; Sheridan R; Sander C; Zavolan M; Tuschl T; Rice CM
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12884-9. PubMed ID: 17616579
[TBL] [Abstract][Full Text] [Related]
39. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
40. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
J Virol; 2019 May; 93(10):. PubMed ID: 30842319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
